Brendan Philp

Brendan Philp is a seasoned professional with a diverse educational background and a wealth of experience in the healthcare and consumer goods industries.

He holds a Study Abroad degree in Spanish Language and Literature from Universidad de Alcala, an MBA in Marketing and Finance & Business Economics from Fordham Gabelli School of Business, and a BBA in International Business from Loyola College in Maryland.

Brendan currently serves as the Worldwide Senior Director and the Injection Platform Leader for Diabetes Care at BD, a role that showcases his strong leadership and strategic skills.

His previous roles at BD include being the Worldwide Senior Director for the Pen Needle Franchise, Associate Director for Worldwide Strategic Marketing, and Senior Brand Manager for BD Medical in the Diabetes Care division.

Prior to his tenure at BD, Brendan gained valuable experience at Novartis Consumer Health, where he held various positions such as Innovation Brand Manager for the Americas DH, Brand Manager for Prevacid24HR, Associate Brand Manager for Benefiber, and Assistant Brand Manager for Gas-X / Maalox / Ex-Lax.

He also contributed to the field of brand management as a Brand Management Intern for Lamisil AT during his time at Novartis Consumer Health.

Before transitioning to the healthcare industry, Brendan honed his skills as a Risk Advisory Services Associate at KPMG LLP.

With a proven track record of success and a comprehensive understanding of marketing, brand management, and strategic planning, Brendan Philp continues to make significant contributions to the organizations he is part of.